Registration
BROWNSTEIN HYATT FARBER SCHRECK, LLP for PIERRE FABRE PHARMACEUTICALS INC.
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues related to drug development, rare disease innovations, and issues impacting the pharmaceutical industry.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY FELDER New | Director of the Office of Legislation, CMS; Counsel, House Energy and Commerce Committee; Counsel, Senate Committee on Homeland Security and Government Affairs; Counsel, House Oversight and Government Reform Committee |
| STEPHEN HOLLAND New | Senior Health Counsel, Health Counsel - House Energy and Commerce Committee (Rep. Frank Pallone); Counsel, Legislative Assistant - Rep. Kurt Schrader |
| ZACHARY PFISTER New | Leg Dir Rep Larry Kissell; Sen Leg Asst Rep Larry Kissell; Leg Asst Rep Larry Kissell; Leg Correspondent Rep Larry Kissell; Leg Correspondent Rep Brad Ellsworth; Staff Asst Rep Brad Ellsworth; Leg Intern Sen Evan Bayh |
| ADAM STEINMETZ New | Policy Advisor - Committee on the Budget, United States House of Representatives |
| DEEMA TARAZI New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| PIERRE FABRE SA | France | France | 100.0% | — |
| PIERRE FABRE FOUNDATION | France | France | 85.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.